Skip to main content
Molecular Therapy logoLink to Molecular Therapy
. 2026 May 12;34(6):3700. doi: 10.1016/j.ymthe.2026.05.001

DPP4/CD32b/NF-κB Circuit: A Novel Druggable Target for Inhibiting CRP-Driven Diabetic Nephropathy

Patrick Ming-Kuen Tang , Ying-Ying Zhang, Jessica Shuk-Chun Hung, Jeff Yat-Fai Chung, Xiao-Ru Huang, Ka-Fai To, Hui-Yao Lan ∗∗
PMCID: PMC13239668  PMID: 42127897

Main text

(Molecular Therapy 29, 365–375; January 2021)

Due to a production error, an incorrect retraction text, referring to a different recently retracted paper, was inadvertently published for this retracted article and its corresponding retraction notice. This has now been corrected online, and we apologize for any inconvenience.

Contributor Information

Patrick Ming-Kuen Tang, Email: patrick.tang@cuhk.edu.hk.

Hui-Yao Lan, Email: hylan@cuhk.edu.hk.


Articles from Molecular Therapy are provided here courtesy of The American Society of Gene & Cell Therapy

RESOURCES